Cedelizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cedelizumab?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target CD4
Clinical data
Identifiers
156586-90-2 N
None
KEGG D03420 YesY
Chemical data
 N (what is this?)  (verify)

Cedelizumab is a monoclonal antibody acting on the immune system.[1] Possible indications include the prevention of organ transplant rejections and the treatment of autoimmune diseases.[2]

References[edit]

  1. ^ WHO Drug Information
  2. ^ The NDA pipeline. F-D-C Development Corporation. 2001.